Bosh sahifaP09 • FRA
add
Pacific Biosciences of California Inc
Yopilish kursi
1,61 €
Kunlik diapazon
1,50 € - 1,59 €
Yillik diapazon
1,05 € - 6,73 €
Bozor kapitalizatsiyasi
457,35 mln USD
Oʻrtacha hajm
5,69 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 39,97 mln | -28,23% |
Joriy xarajat | 69,21 mln | -24,66% |
Sof foyda | -60,72 mln | 9,19% |
Sof foyda marjasi | -151,94 | -26,54% |
Har bir ulushga tushum | -0,17 | 37,04% |
EBITDA | -44,96 mln | 35,71% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 471,15 mln | -38,64% |
Jami aktivlari | 1,45 mlrd | -23,62% |
Jami passivlari | 996,93 mln | -12,13% |
Umumiy kapital | 453,12 mln | — |
Tarqatilgan aksiyalar | 273,86 mln | — |
Narxi/balansdagi bahosi | 0,98 | — |
Aktivlardan daromad | -9,46% | — |
Kapitaldan daromad | -10,03% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -60,72 mln | 9,19% |
Operatsiyalardan naqd pul | -45,46 mln | 30,25% |
Sarmoyadan naqd pul | 23,06 mln | -90,48% |
Moliyadan naqd pul | 812,00 ming | 203,97% |
Naqd pulning sof oʻzgarishi | -21,59 mln | -112,24% |
Boʻsh pul | -13,40 mln | 88,84% |
Haqida
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
Tashkil etilgan
2004
Sayt
Xodimlar soni
796
